Ionis Pharmaceuticals (IONS) Current Taxes (2009 - 2026)

Ionis Pharmaceuticals' Current Taxes history runs 11 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Current Taxes rose 2180.95% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 2180.95% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 7879.41% from the prior year.
• Current Taxes improved to $2.9 million in Q1 2026 per IONS's latest filing, from $2.7 million in the prior quarter.
• Across five years, Current Taxes topped out at $31.1 million in Q3 2023 and bottomed at $14000.0 in Q2 2022.
• The 5-year median for Current Taxes is $901000.0 (2022), against an average of $5.3 million.
• Across the five-year window, Current Taxes soared 194087.5% in 2023 and plunged 99.87% in 2024, its largest moves.
• Year by year, Current Taxes stood at $6.2 million in 2022, then sank by 65.58% to $2.2 million in 2023, then sank by 98.42% to $34000.0 in 2024, then surged by 7879.41% to $2.7 million in 2025, then gained by 5.93% to $2.9 million in 2026.
• Per Business Quant, the three latest IONS Current Taxes figures stand at $2.9 million (Q1 2026), $2.7 million (Q4 2025), and $101000.0 (Q3 2025).